Drug Type AAV based gene therapy |
Synonyms- |
Target |
Action inhibitors |
Mechanism AT III inhibitors(Antithrombin-III inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hemophilia A | Preclinical | France | 01 May 2018 | |
| Hemophilia A | Preclinical | France | 01 May 2018 | |
| Hemophilia B | Preclinical | France | 01 May 2018 | |
| Hemophilia B | Preclinical | France | 01 May 2018 |





